-- Xiamen Amoytop Biotech (SHA:688278) plans to raise funds of up to 1.53 billion yuan from the issuance of convertible bonds, according to a Thursday disclosure on the Shanghai bourse.
The proceeds will be used to invest in a new drug research and development project, a biotechnology innovation center project and the construction of a production line.